RGC’s Debt-to-Equity Ratio at 0.01: What It Means for Regencell Bioscience Holdings Ltd’s Future

The market performance of Regencell Bioscience Holdings Ltd’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $25.00 on 06/16/25, while the lowest value for the same duration was $0.08 on 07/22/24.

52-week price history of RGC Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Regencell Bioscience Holdings Ltd’s current trading price is 140.00% away from its 52-week high, while its distance from the 52-week low is 75147.52%. The stock’s price range during this period has spanned from $0.08 to $25.00. In the Healthcare sector, the Regencell Bioscience Holdings Ltd’s shares surpassed a trading volume of approximately 5.05 million for the day, which was noticeably lower compared to the average daily volume of 9.12.43 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Regencell Bioscience Holdings Ltd (RGC) has experienced a quarterly rise of 12224.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 29.67B and boasts a workforce of 12 employees.

Making Sense of Trading Volume and Moving Average Data

Examining RGC’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RGC stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

RGC Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 46053.85% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 41734.86%. Over the past 30 days, the price of RGC has fallen by 467.16%. And in the last five days, it has surged by 256.28%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.